Pharmacist

Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

Retrieved on: 
Monday, April 1, 2024
Technology, Medical Devices, Hospitals, FDA, Health Technology, Software, Biotechnology, General Health, Pharmaceutical, Health, SYR, Novum, LVP, EMR, Patient, State, Food and Drug Administration, CQI, Hospital, Pharmacist, Baxter International, Computer security, Safety, Nursing, Baxter, Medicine, Pump, Food, Medical device

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software.
  • Offering the Novum IQ LVP in the U.S. demonstrates Baxter’s commitment to continued innovation in advancing infusion therapy.
  • “The Novum IQ platform represents a meaningful shift in how connected and intelligent infusion therapy can impact the way clinicians provide care.
  • IQ Enterprise Connectivity Suite, a scalable all-in-one server, integration engine and software application platform, designed to simplify infusion system connectivity for the Novum IQ Infusion Platform.

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Retrieved on: 
Thursday, March 21, 2024
Supermarket, Health Technology, Pharmaceutical, Oncology, Teens, Medical Devices, Parenting, Infectious Diseases, Retail, Genetics, Fitness & Nutrition, Cardiology, Health, Seniors, Practice Management, Men, General Health, Family, Consumer, Diabetes, Other Retail, Other Health, Biometrics, Diagnosis, Temperature, Patient, Pharmacy, Pharmacist, Prescription, Babson, Insurance, Centrifugation, Texas Pharmacy Association, Collection, Blood, FDA

Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.

Key Points: 
  • Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
  • BetterWay brings blood testing into the 21st century, making it less invasive, more convenient, and accessible for consumers.
  • “Blood testing hasn’t changed much in over 70 years,” said David Stein, Babson’s chief executive officer.
  • Without the need for a phlebotomist, Babson can bring medically accurate blood testing to new, more convenient settings such as community pharmacies.

TrueRx: AI-Powered Monitoring and Alert System Is the Industry’s First Prescription for Fraud

Retrieved on: 
Wednesday, March 20, 2024
Software, Pharmaceutical, Internet, Health, Artificial Intelligence, Technology, Mobile, Wireless, Other Health, Risk, Patient, Pharmacy, Algorithm, Pharmacist, Prescription

DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription fraud.

Key Points: 
  • DrFirst’s new prescription monitoring solution – TrueRx – will give the nation’s pharmacies their first-ever standardized alert system to protect against prescriber identity and prescription fraud.
  • There has been no system to aid pharmacists who receive fraudulent prescriptions.
  • When a prescription arrives at the pharmacy, digital fingerprint analysis alerts the pharmacist if one or more “behavior outliers” are detected that are typical in cases of stolen identity.
  • As methods of identity fraud become more complex, the algorithms will learn new behaviors to better prepare for the next style of attack.

BioTek reMEDys Promotes Awareness and Education for Bleeding Disorders Awareness Month

Retrieved on: 
Wednesday, March 20, 2024
Research, Infectious Diseases, Public Policy, Government, Healthcare Reform, Biotechnology, Health, Pharmaceutical, General Health, Science, Diagnosis, Coagulopathy, Haemophilia, Caregiver, Education, Patient, Von Willebrand disease, Pharmacist, Blood, Physician, BioTek

In recognition of March being Bleeding Disorders Awareness Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use and treatments for patients with bleeding disorders and conditions.

Key Points: 
  • In recognition of March being Bleeding Disorders Awareness Month , BioTek reMEDys , a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use and treatments for patients with bleeding disorders and conditions.
  • “Bleeding Disorders Awareness Month is an opportunity and a reminder to advocate for education as a priority throughout the healthcare continuum as we work towards recognizing the challenging journey patients often have on the way to a correct diagnosis and treatment."
  • Each March, the community calls attention to inheritable blood and bleeding disorders during Bleeding Disorders Awareness Month.
  • To learn more about hemophilia, von Willebrand disease, rare factor disorders and other bleeding disorders, visit hemophilia.org .

McKesson Invites Community Pharmacists to Push the Industry Forward, Together

Retrieved on: 
Thursday, March 14, 2024
Vitamins, Supplements, Other Retail, Fitness & Nutrition, Specialty, Other Health, Training, Pharmaceutical, Health, Retail, Education, Community, Conference, Face, Pharmacy, Patient, Head, Knowledge, Pharmacist, McKesson Corporation, Aluminium, Nightclub

The annual event is the destination for community pharmacists to come together to strengthen the overall health of pharmacy and elevate the role they play in people’s lives.

Key Points: 
  • The annual event is the destination for community pharmacists to come together to strengthen the overall health of pharmacy and elevate the role they play in people’s lives.
  • McKesson ideaShare will culminate by celebrating the Health Mart Pharmacy of the Year ahead of a closing concert headlined by Harry Connick, Jr.
    “New Orleans is known for its strength and resilience as is our community pharmacy industry.
  • McKesson ideaShare’s collaborative environment will celebrate our industry while addressing key challenges head-on,” said Scott Miller, president, Strategic, Community, and Specialized Pharmacy, McKesson.
  • This exclusive benefit is extended on behalf of McKesson to support independent pharmacy success in local communities across the U.S.

Surescripts’ Unmatched Healthcare Interoperability Delivered Intelligence Sharing at Scale in 2023

Retrieved on: 
Monday, March 11, 2024
Practice Management, Technology, Managed Care, Other Health, Health, General Health, Healthcare Reform, Pharmaceutical, Other Technology, Networks, Public Policy, Government, Hospital, Organization, Growth, Surescripts, Patient, Pharmacist, Ground substance, Electronic prescribing, Practitioner, Physician, Nursing

At the same time, annual growth in PCPs using electronic prescribing averaged just 1.7% from 2019 to 2023, compared to 10% among non-PCPs.

Key Points: 
  • At the same time, annual growth in PCPs using electronic prescribing averaged just 1.7% from 2019 to 2023, compared to 10% among non-PCPs.
  • “We see responsibilities shifting across the care team as other types of clinicians take on more clinical responsibility—including pharmacists, among whom e-prescribing jumped dramatically in 2023,” Harvey explained.
  • Together, they found and shared 1.89 billion clinical documents representing 31% of the Carequality interoperability framework’s average monthly exchange activity in 2023.
  • In 2023, 881,070 pharmacists, prescribers, payers and other healthcare organizations—including 22,556 pharmacies—used Clinical Direct Messaging to send and receive secure, HIPAA-compliant messages.

Visionary Holdings Inc. Announces Board Change

Retrieved on: 
Thursday, April 4, 2024
Canadian Pharmacists Journal, GV, Void coefficient, The Company, CHG, Kealey, Canada India Foundation, Public policy, Artificial intelligence, AECL, Pharmacist, University, Queen's University, Pharmacy, Pharmacy school, Kent State University, School

The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.

Key Points: 
  • The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.
  • Mr. Kealey has served as the Chairman of the Board since November 2022 to June 2023.
  • The Board has determined that Mr. Kealey qualifies as an "Independent Director" within the meaning of Nasdaq Rule 5605.
  • Following Mr. Kealey's appointment, the Board of the Company is comprised of five (5) directors, including four (4) independent directors.

Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care

Retrieved on: 
Wednesday, April 3, 2024
Real-World Evidence, RN, Success, BP, RRMM, Doctor of Pharmacy, BCPS, Selinexor, Incidence, Partnership, Physician, Manufacturing, Bachelor of Pharmacy, DNP, Nursing, Prior authorization, Pharmacist, Roger Hawkins (drummer), CAPM, MPA, BSN, Therapy, RPH, Pharmacy, Outcome, Safety, Infrared spectroscopy correlation table, Best practice, FCS, PACS, OCN, Data, Metric, Health care

FORT MYERS, Fla., April 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) leaders and pharmacy experts will share insights and best practices in specialty pharmacy operations and dispensing that are contributing to positive patient outcomes at the NCODA 2024 Spring Forum in Dallas. The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.

Key Points: 
  • The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.
  • "Our Rx To Go team members continue to set the standard of excellence for medically-integrated oncology pharmacy and support services," said FCS President & Managing Physician Lucio Gordan, MD .
  • "They are well-equipped to contribute top-tier knowledge to help steer the future of oncology care."
  • NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.

Empowering Change: AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship

Retrieved on: 
Wednesday, April 3, 2024
Pharmacist, Health, Doctor of Pharmacy, Health equity, Partnership, Diabetes, Howard University, Knowledge, Regression analysis, Research, Moda Health, Walker, Chronic kidney disease, Geography, Hypertension, Collection, Medicine, Assistant director, Nursing

Sinclair brings a wealth of knowledge and a passion for health care research with a keen interest in addressing health disparities.

Key Points: 
  • Sinclair brings a wealth of knowledge and a passion for health care research with a keen interest in addressing health disparities.
  • The collaboration among AMCP Foundation and intern alumni Carly Rodriguez, PharmD, FAMCP VP & Chief Pharmacy Officer, Moda Health, and Courtney Walker, PharmD, RPh, Medical Account Director – Employers West, Novo Nordisk Inc. represents a critical alliance in health disparities research, focusing on unveiling insights into medication adherence disparities.
  • This strategic partnership exemplifies the synergy essential for impactful research, emphasizing a collective commitment to addressing health disparities.
  • In her unique role, Sinclair is at the forefront of research addressing health disparities related to GLP-1s, medications crucial in diabetes treatment.

CVS Health® expands pharmacy tuition assistance and scholarship programs

Retrieved on: 
Wednesday, April 3, 2024
Health, CVS, Face, Achievement Medal, Doctor of Pharmacy, Health equity, Partnership, Education, Patient, CVS Pharmacy, Pharmacist, Student, CVS Health, AACP, FCCP, Nursing

WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.

Key Points: 
  • Investing in the future of community pharmacy helps ease students' financial barriers and challenges, and promotes a stable and inclusive pharmacy workforce pipeline
    WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.
  • The CVS Health PharmD tuition assistance program is available to all eligible CVS Pharmacy interns and consists of a $20,000 award per year.
  • CVS Pharmacy will continue to advance the practice of pharmacy and provide more opportunities for students to enter this important area of health care."
  • In the fall, the program will be expanded to CVS Pharmacy interns in their final two years of pharmacy education, with $20,000 available for each year while working as an intern for CVS Pharmacy.